Roderike Pohl
Nessuna posizione attualmente
Profilo
Roderike Pohl was Vice President-Research for Biodel, Inc. from December 2003 to December 13, 2008.
He was a Scientific Consultant for Steiner Ventures LLC from August 2003 to November 2003.
Dr. Pohl was Vice President of Preclinical Research MannKind Corporation from December 1998 to July 2003.
He received a PhD from the University of Connecticut.
Precedenti posizioni note di Roderike Pohl
Società | Posizione | Fine |
---|---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Direttore Tecnico/Scientifico/R&S | 13/12/2008 |
Pharmaceutical Discovery Corp. | Direttore Tecnico/Scientifico/R&S | 01/07/2003 |
Formazione di Roderike Pohl
University of Connecticut | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
Pharmaceutical Discovery Corp. | Health Technology |
- Borsa valori
- Insiders
- Roderike Pohl